The Most Valuable Commodity Is Information!

#SuvenLife initiates Phase 2A trial of SUVN-502 in US in Alzheimer’s disease pic.twitter.com/at1I4d1AoH



initiates Phase 2A trial of SUVN-502 in US in Alzheimer’s disease

Subscribe To Our Free Newsletter
All News    ,

Latest News